Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
52%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
47%
ALSO IN FTXH
FTXH
51
HOLDINGS
48%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 16.9% | 8.2% | 8.2% | |
| ABBVIE INC | 7.4% | 7.7% | 7.4% | |
| JOHNSON & JOHNSON | 9.3% | 6.9% | 6.9% | |
| MERCK & CO. INC. | 5.2% | 6.8% | 5.2% | |
| GILEAD SCIENCES INC | 4.1% | 3.9% | 3.9% | |
PBPH Overweight Relative to FTXH
| ELI LILLY & CO | 8.7% | |
| ASTRAZENECA PLC | 4.8% | |
| NOVARTIS AG | 4.2% | |
| NOVO NORDISK A/S-B | 2.5% | |
| JOHNSON & JOHNSON | 2.4% | |
| SANOFI-AVENTIS | 1.9% | |
| GSK PLC | 1.8% | |
| CSL LIMITED | 1.3% | |
| TAKEDA PHARMACEUTICAL CO LTD | 1.3% | |
| ARGEN-X SE | 1.1% |
PBPH Underweight Relative to FTXH
| PFIZER INC | -3.8% | |
| VIATRIS, INC. | -3.5% | |
| BIOGEN IDEC INC | -3.2% | |
| UNITED THERAPEUTICS CORP | -3.0% | |
| ZOETIS INC | -2.8% | |
| INCYTE CORP | -2.8% | |
| EXELIXIS INC | -2.2% | |
| REGENERON PHARMACEUTICALS | -2.1% | |
| JAZZ PHARMACEUTICALS PLC | -2.0% | |
| HALOZYME THERAPEUTICS INC | -1.8% |